Statins v placebo or usual care for stroke reduction*
| Weighted event rates | |||||
|---|---|---|---|---|---|
| Outcomes at 0.3–6.1 years | Number of trials (n) | Intervention | Control | RRR (95% CI) | NNT (CI) |
| *Abbreviations defined in glossary; weighted event rates, RRR, NNT, and CI calculated from data in article using a fixed effects model. | |||||
| All stroke | 26 (94 128) | 2.9% | 3.4% | 20% (14 to 25) | 222 (163 to 350) |
| Fatal stroke | 15 (71 967) | 0.68% | 0.69% | 8% (−10 to 23) | Not significant |
| Haemorrhagic stroke | 7 (43 758) | 0.29% | 0.34% | 9% (−26 to 34) | Not significant |
